| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.36 | 9e-23 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-16 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-15 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.36 | 8e-12 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.29 | 8e-09 |